Us Cancer Biopsy Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Cancer Biopsy Market was valued at USD 5.02 Billion in 2022 and is projected to reach USD 8.50 Billion by 2030, growing at a CAGR of 7.20% from 2024 to 2030.
The US Cancer Biopsy Market has been steadily growing in recent years, driven by an increasing demand for early diagnosis and personalized treatment plans. Biopsy is a crucial diagnostic tool used to detect cancer in patients, and with advancements in technology, the market for cancer biopsies has been expanding rapidly. In fact, the market is projected to grow at a significant pace over the next decade, offering numerous opportunities for medical professionals and technology providers alike.
One key trend in the cancer biopsy market is the growing adoption of liquid biopsy. This non-invasive diagnostic technique analyzes blood samples to detect genetic mutations and abnormal cell activity that may indicate cancer. Liquid biopsy is especially valuable for detecting cancers in their early stages, where traditional methods might miss key signs of tumor growth. As this technology becomes more accurate and accessible, it's expected to play a vital role in revolutionizing cancer diagnosis.
Additionally, advancements in imaging technologies, such as high-resolution ultrasound and MRI-guided biopsies, have improved the accuracy and efficiency of cancer diagnosis. These technologies enable physicians to locate tumors more precisely, reducing the need for invasive procedures and minimizing patient discomfort. This shift towards less invasive methods is expected to drive further growth in the cancer biopsy market.
One of the most exciting developments in this field is the rise of AI and machine learning in cancer diagnosis. AI-driven platforms are being used to analyze biopsy samples, providing doctors with more accurate and timely results. These tools can identify patterns and anomalies in tissue samples that might be overlooked by the human eye, improving the precision of diagnoses and enhancing treatment outcomes.
The market is also influenced by demographic shifts, such as the aging population and rising awareness of cancer. As the number of cancer cases continues to increase, there is a growing need for reliable and efficient diagnostic tools, which further fuels the demand for biopsies. With government initiatives supporting early cancer detection and ongoing innovations in biopsy technologies, the future of the US Cancer Biopsy Market looks promising.
Another factor driving the growth of this market is the increasing prevalence of lifestyle-related diseases. Smoking, poor diet, and sedentary lifestyles have led to higher rates of certain cancers, especially lung, colorectal, and breast cancer. As a result, there is an urgent need for more frequent and effective cancer screening, which boosts demand for biopsies.
Furthermore, new diagnostic techniques and treatments are helping to reduce the need for traditional surgical biopsies, allowing patients to undergo quicker, more efficient procedures. As a result, the US Cancer Biopsy Market is expected to see continued innovation and expansion, benefiting both patients and healthcare providers.
In parallel, healthcare policies and regulations are evolving to better support cancer diagnosis and treatment. These changes are helping to improve the accessibility and affordability of cancer biopsy procedures, making them more widely available to patients across the country.
While liquid biopsy and advanced imaging technologies lead the way, the overall market is diverse and includes a variety of biopsy methods, such as needle biopsy, endoscopic biopsy, and surgical biopsy. Each of these methods serves a unique purpose, depending on the location and type of cancer being tested for. As technology continues to evolve, it’s likely we’ll see even more innovative approaches to cancer diagnosis and treatment, shaping the future of the US Cancer Biopsy Market.
Get an In-Depth Research Analysis of the Global Cancer Biopsy Market Size And Forecast [2025-2032]
Â
Qiagen N.V.
Illumina
Inc
ANGLE Plc
Myriad Genetics
Hologic
Inc
Biocept
Inc
Thermo Fisher Scientific
Inc
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL
Inc
Guardant Health
Exact Sciences Corporation
Freenome Holdings
Inc
Oncimmune
Chronix Biomedical
Inc
Personal Genome Diagnostics Inc
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Cancer Biopsy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Cancer Biopsy Market
Needle Biopsy
Excisional Biopsy
Incisional Biopsy
Endoscopic Biopsy
Fine-Needle Aspiration Biopsy (FNAB)
Imaging-guided Biopsy
Optical Biopsy
Molecular Biopsy
Liquid Biopsy
Electromagnetic Navigation Biopsy
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Gynecological Cancer
Hospitals
Diagnostic Laboratories
Research Institutions
Specialty Clinics
Ambulatory Surgical Centers
Tissue Samples
Blood Samples
Saliva Samples
Urinary Samples
Bone Marrow Samples
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Cancer Biopsy Market Research Analysis
1. Introduction of the Global Cancer Biopsy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Cancer Biopsy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Cancer Biopsy Market, By Type
6. Global Cancer Biopsy Market, By Application
7. Global Cancer Biopsy Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Cancer Biopsy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/